[ 99 , 100 ] indicates a strong trend towards a dose-response relationship of increased hospitalization and death, due to heart failure in patients with underlying heart failure who received increasing amounts of β 2 -agonist.
← all excerpts
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.
2
—
—
The sentences
A LABA-ICS combination tended to reduce the risk of an exacerbation more than a LABA alone, although this did not reach statistical significance (OR 0.90; 95% CI, 0.80-1.01).